CA 125: History, Current Status, and Future Prospects

by Robert C., Jr Bast, Robert C. Knapp
Published 2020-12-01

Tumor Markers: An Overview

by Ajay G Nayak, Laxmikanth Chatra
Published 2010-01-01

Inhibin as a tumor marker of ovarian cancer in postmenopausal women

by Modarres Gilani M, Karimi M
Published 2010-05-01

Biochemical profile of bile fluid in patients with malignant cholestasis in comparison with cholestasis due to biliary stone

by Hassan Teheri, Naser Ghaemian, Yaser Taghavi, Javad Shokry- Shirvani
Published 2015-07-01

EVALUATION OF CLINICAL USE HABİTS OF TUMOR MARKER TESTS

by Soycan MIZRAK
Published 2020-08-01

Inhibin as A Tumor Marker in Postmenopausal Women with Ovarian Malignancies

by Mitra Modarres Guilani, Mahshid Karimi
Published 2014-04-01

Evaluation of diagnostic accuracy of RMI and ROMA indices in comparison to HE4 and CA125 parameters for estimating the risk of malignancy of adnexal masses.

by Afsaneh Tehranian, Akram Ghahghaei-Nezamabadi, Nasim Yarmohammadi, Maryam Ganjeh, Khadije Maajaani, Reihaneh Aghajani
Published 2021-05-01

Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer

by Zhong Y, Fan Q, Zhou Z, Wang Y, He K, Lu J
Published 2020-05-01

Serum ferritin in healthy women and breast cancer patients

by Ćujić Danica, Stefanoska Ivana, Golubović Snežana
Published 2011-01-01

Tumor markers: An overview

by G Suresh Babu, A Naga Supriya, N Govind Raj Kumar, P Swetha
Published 2012-01-01

A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Refractory to Epirubicin That Showed Marked Decrease in Tumor Markers after Transcatheter Arterial Infus...

by Hiroki Nishikawa, Tadashi Inuzuka, Haruhiko Takeda, Jun Nakajima, Azusa Sakamoto, Sinichiro Henmi, Tetsurou Ishikawa, Sumio Saito, Ryuichi Kita, Toru Kimura, Yukio Osaki, Yorimitsu Koshikawa
Published 2011-06-01

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial

by Masahiro Hatooka, Tomokazu Kawaoka, Hiroshi Aikata, Yuki Inagaki, Kei Morio, Takashi Nakahara, Eisuke Murakami, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Kazuo Awai, Keiichi Masaki, Koji Waki, Hirotaka Kohno, Hiroshi Kohno, Takashi Moriya, Yuko Nagaoki, Toru Tamura, Hajime Amano, Yoshio Katamura, Kazuaki Chayama
Published 2018-06-01

Research progress on GP73 in malignant tumors

by Liang R, Liu Z, Piao X, Zuo M, Zhang J, Liu Z, Li Y, Lin Y
Published 2018-10-01

Aptamer-based approaches for in vitro molecular detection of cancer

by Hadi Bakhtiari, Abbas Ali Palizban, Hossein Khanahmad, Mohammad Reza Mofid
Published 2020-01-01

Pancreatic Adenocarcinoma Masquerading as Idiopathic Chronic Pancreatitis with Delayed Diagnosis

by Sunil Badami, Htay Htay Kyi, Sunil Upadhaya, Samer Al Hadidi
Published 2017-09-01

The Carcinoembryonic Antigen (CEA): Past, Present, and Future

by Phil Gold, Neil Goldberg
Published 2020-12-01

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

by Takahiro Maeda, Hiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao, Kengo Kanayama, Susumu Maruta, Yuko Kusakabe, Tomoko Saito, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Ryo Nakagawa, Ryosuke Muroyama, Tatsuo Kanda, Hitoshi Maruyama, Naoya Kato
Published 2019-11-01

Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma

by Zhongqing Chen, Ying Wang, Min Fang
Published 2020-02-01

CA125, CEA, CA19-9, and Heteroploid Cells in Ascites Fluid May Help Diagnose Peritoneal Carcinomatosis in Patients with Gastrointestinal and Ovarian Malignancies

by Deng L, Guo S, Li H, You X, Song Y, Su H
Published 2020-10-01

HE4 Gene Overexpression in Ovarian Cancer

by A Shahi, E Moslemi, A Izadi
Published 2016-03-01